Skip to main content

Advertisement

Log in

The molecular basis of amyloidosis

  • Published:
Cellular and Molecular Life Sciences CMLS Aims and scope Submit manuscript

Abstract.

Amyloidoses are diseases, including some currently prominent such as Alzheimer's disease, bovine spongiform encephalophaty (BSE) and Type II diabetes, in which soluble proteins are deposited in a specific, highly stable, fibrillar form. The amyloid fibrils are made up of protofilaments whose molecular structure is composed of pairs of β-sheets in a helical form that allows them to be continuously hydrogen-bonded along the length of the fibril. The observation that similar fibrils are generated from different proteins indicates that fibril formation is accompanied by structural conversion. The transmissible spongiform encephalopathies, such as BSE and kuru, involve an infectious agent identified with the prion protein. The properties of the agent are more consistent with prion amyloid than the protein itself, suggesting infectivity in these diseases is equivalent to the 'seeding' of amyloid fibrils at a new site.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Serpell, L., Sunde, M. & Blake, C. The molecular basis of amyloidosis. CMLS, Cell. mol. life sci. 53, 871–887 (1997). https://doi.org/10.1007/s000180050107

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s000180050107

Navigation